benserazide has been researched along with Nervous System Disorders in 3 studies
Benserazide: An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone.
benserazide : A carbohydrazide that results from the formal condensation of the carboxy group of DL-serine with the primary amino group of 4-(hydrazinylmethyl)benzene-1,2,3-triol. An aromatic-L-amino-acid decarboxylase inhibitor (DOPA decarboxylase inhibitor) that does not enter the central nervous system, it is used as its hydrochloride salt as an adjunct to levodopa in the treatment of parkinsonism. By preventing the conversion of levodopa to dopamine in the periphery, it causes an increase in the amount of levodopa reaching the central nervous system and so reduces the required dose. Benserazide has no antiparkinson actions when given alone.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dill, P | 1 |
| Wagner, M | 1 |
| Somerville, A | 1 |
| Thöny, B | 1 |
| Blau, N | 1 |
| Weber, P | 1 |
| Martinez-Campos, A | 1 |
| Giovannini, P | 1 |
| Cocchi, D | 1 |
| Zanardi, P | 1 |
| Parati, EA | 1 |
| Caraceni, T | 1 |
| Müller, EE | 1 |
| Azuma, T | 1 |
| Suzuki, T | 1 |
| Sakoda, S | 1 |
| Mizuno, R | 1 |
| Tsujino, S | 1 |
| Kobayashi, T | 1 |
| Kishimoto, S | 1 |
| Hiraga, T | 1 |
| Matsubara, T | 1 |
| Yoshida, S | 1 |
1 review available for benserazide and Nervous System Disorders
| Article | Year |
|---|---|
Growth hormone secretion in neurological disorders.
Topics: Benserazide; Disease Models, Animal; Dopamine; Growth Hormone; Humans; Huntington Disease; Levodopa; | 1981 |
2 other studies available for benserazide and Nervous System Disorders
| Article | Year |
|---|---|
Child neurology: paroxysmal stiffening, upward gaze, and hypotonia: hallmarks of sepiapterin reductase deficiency.
Topics: 5-Hydroxytryptophan; Alcohol Oxidoreductases; Behavior; Benserazide; Consanguinity; Developmental Di | 2012 |
Effect of long-term L-threo-3,4-dihydroxyphenylserine administration on alpha 2-adrenergic receptors in platelet membranes in neurologic disorders.
Topics: Aged; Amyloidosis; Benserazide; Blood Platelets; Dose-Response Relationship, Drug; Droxidopa; Drug T | 1991 |